Market Overview The US antibody drug conjugate market is experiencing significant growth as this targeted cancer therapy enable precise tumor cell killing while minimizing healthy tissue exposure. The US Antibody Drug Conjugate Market is projected to exceed USD 18.5 billion through 2030, driven by cancer burden, targeted therapy advancement, and precision oncology adoption. US antibody drug...